Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Other Non-Current Assets (2021 - 2025)

Rani Therapeutics Holdings (RANI) has 3 years of Other Non-Current Assets data on record, last reported at $293000.0 in Q2 2025.

  • For Q2 2025, Other Non-Current Assets rose 19.11% year-over-year to $293000.0; the TTM value through Jun 2025 reached $293000.0, up 19.11%, while the annual FY2024 figure was $246000.0, 0.0% changed from the prior year.
  • Other Non-Current Assets reached $293000.0 in Q2 2025 per RANI's latest filing, up from $246000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $293000.0 in Q2 2025 and bottomed at $246000.0 in Q4 2023.
  • Average Other Non-Current Assets over 3 years is $253833.3, with a median of $246000.0 recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: changed 0.0% in 2024, then rose 19.11% in 2025.
  • A 3-year view of Other Non-Current Assets shows it stood at $246000.0 in 2023, then changed by 0.0% to $246000.0 in 2024, then increased by 19.11% to $293000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $293000.0 in Q2 2025, $246000.0 in Q1 2025, and $246000.0 in Q4 2024.